Open access
Oct 2026
Targeted therapies in immune thrombocytopenia: Current landscape and future directions
The current understanding of the biological rationale underlying targeted therapies in ITP is summarized and the available evidence from pivotal clinical trials and real-world studies are critically discussed.
T. González-López
· Therapeutic Advances in Hema... · 0 citations